Health-related quality of life among people living with HIV/AIDS in Togo: individuals and contextual effects

BMC Res Notes. 2019 Mar 15;12(1):140. doi: 10.1186/s13104-019-4171-x.

Abstract

Objective: The objective of this study is to assess the quality of life and to identify factors associated with good global quality of life among people living with HIV/AIDS (PLWHA) in Togo.

Results: In total, 880 PLWHA with mean age (standard deviation) of 39.6 (10.1) years, were interviewed. Most of them (78.4%) were female. The global score of quality of life was ranged from 42.6 to 112, with a mean (standard deviation) estimated at 86.3 ± (13.3). More than the three-quarters (76.2%) of the participants had a good global quality of life. In multivariate analysis, secondary education level or higher (adjusted odds ratio = 1.78, 95% confident interval (CI) [1.10-2.85]), living in Kara health region (adjusted odds ratio = 4.39, 95% CI [2.94-6.57]), being on antiretroviral therapy (adjusted odds ratio = 6.99, 95% CI [4.11-11.9]) and HIV sero-status disclosure (adjusted odds ratio = 1.83, 95% CI [1.28-2.61]) were associated with a better overall quality of life (score ≥ 77.3).

Keywords: PLWHA; Quality of life; Togo.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / physiopathology*
  • Acquired Immunodeficiency Syndrome / virology
  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • Cross-Sectional Studies
  • Female
  • HIV / drug effects
  • HIV / physiology
  • HIV Infections / drug therapy
  • HIV Infections / physiopathology*
  • HIV Infections / virology
  • Health Surveys / methods
  • Health Surveys / statistics & numerical data*
  • Humans
  • Male
  • Medication Adherence / statistics & numerical data
  • Middle Aged
  • Multivariate Analysis
  • Quality of Life*
  • Risk Factors
  • Togo

Substances

  • Anti-Retroviral Agents